Navigation Links
NanoPass Technologies Ltd. and Elcam Medical Enter Into a Strategic Partnership

NanoPass Technologies Ltd. and Elcam Medical Enter Into a... -- REHOVOT and KIBBUTZ BAR'AM, Israel, September 14, 2010 /PRNewswire/ --

Advanced Search Search

  1. Send a release
  2. Member sign in
  3. Become a member
  4. For journalists
  5. Global sites
PR Newswire: news distribution, targeting and monitoring
  1. Products & Services
  2. Knowledge Center
  3. Browse News Releases
  4. Contact PR Newswire
Nanotechnology, Biotechnology, Health Care & Hospitals, Medical Pharmaceuticals, Contracts, Joint Ventures, Clinical Trials & Medical Discoveries Click to view news release full screen  

NanoPass Technologies Ltd. and Elcam Medical Enter Into a Strategic Partnership


REHOVOT and KIBBUTZ BAR'AM, Israel, September 14, 2010 /PRNewswire/ -- NanoPass Technologies Ltd. ("NanoPass"), a privately held company that develops novel microneedle solutions for painless delivery of drugs and vaccines, announced today that it has recently secured a strategic investment and manufacturing agreement with a leading medical device manufacturer, Elcam Medical ("Elcam"). Existing investors including Ofer Hi Tech and D Partners, also participated in the round.

As part of the investment, Mr. Ehud Raivitz, Elcam's CEO, and Mr. Ilan Neugarten of D Partners, will join NanoPass's Board of Directors. Ehud Raivitz remarked, "We are happy to enter into this partnership with NanoPass. I have been impressed by their innovative technology, positive clinical data and achievements. I look forward to leveraging Elcam's capabilities in production and engineering for the mutual benefit of both companies. The collaboration with NanoPass will enable Elcam to provide its customers with access to the most advanced intradermal delivery technology that can address their needs in various applications."

Dr. Yotam Levin, Chief Executive Officer of NanoPass, commented, "We are excited to enter into this strategic partnership with Elcam, a long time supplier of disposable medical products for the medical and pharma industries. We see a significant synergy between our companies. Along with the regulatory approvals we have recently obtained from the FDA and other regulatory bodies, securing a reliable and highly experienced manufacturer is a key component towards full commercialization of our products. The investment will allow NanoPass to develop additional pharmaceutical clients and prepare for market launch."

About NanoPass Technologies Ltd.

NanoPass Technologies was founded by Dr. Shuki Yeshurun under the auspices of the Naiot Technological Incubator. The company is backed by prominent Israeli and US investors including Ofer Hi Tech, D Partners, WFD Ventures, and more recently, Elcam Medical.

About NanoPass's MicronJet Device

MicronJet is a microneedle-based device for ID delivery of vaccines and drugs. The device allows for consistent, reliable, and simple delivery of the drugs directly into the skin. MicronJet has proven efficacy and safety in multiple applications including seasonal flu vaccines, insulin and lidocaine. MicronJet is approved for marketing in various leading territories.

NanoPass has recently concluded the world's first intradermal h1n1 pandemic flu vaccine study, demonstrating equivalent immunogenicity to intramuscular delivery using 20% of the dose. In other clinical trials conducted by NanoPass and third parties, it has been shown that injecting a seasonal influenza vaccine directly into the skin allows for the reduction of the dose required for the same immune response ("dose sparing"). Further, using an equivalent dose may actually increase a vaccine's immunogenicity.

About Elcam Medical

Elcam Medical (Bar-Am, Israel) is a leading worldwide OEM supplier, servicing the medical industry, specializing in the areas of Fluid Management, Vital Signs Monitoring and Drug Delivery.

Contact: Yotam Levin +972-8-9462905 +972-523-392727

SOURCE NanoPass Technologies LTD.
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Energy technologies not enough to sufficiently reduce carbon emissions, NYUs Hoffert concludes
2. BioSpecifics Technologies Corp. to Present at Rodman & Renshaw 12th Annual Healthcare Conference
3. Reportlinker Adds Proteomics - Technologies, Markets and Companies
4. Reportlinker Adds Nanobiotechnologies- Applications, Markets and Companies
5. Statement From Sicel Technologies, Inc.
6. Medisafe 1 Technologies Announces 1-5 Stock Dividend
7. Reportlinker Adds Manufacturing of Biologics - Increasing Demand for Monoclonal Antibodies and Recombinant Proteins Drives Increases in Capacities and Innovative Production Technologies
8. TriLink BioTechnologies to Sponsor Take Me Out to the Ballgame, a SAY San Diego Event Benefiting San Diego Families in Need
9. Life Technologies and SG Biofuels Complete Sequence of Jatropha Genome
10. Novel Stem Cell Therapy From Cellonis Biotechnologies Can Help Children With Diabetes Get Back Their Normal Lives
11. Looking to leap forward on laser and photodetector technologies
Post Your Comments:
(Date:6/23/2016)... ... June 23, 2016 , ... ... and Mold) microbial test has received AOAC Research Institute approval 061601. , “This ... introduced last year,” stated Bob Salter, Vice President of Regulatory and Industrial Affairs. ...
(Date:6/23/2016)... ... ... Supplyframe, the Industry Network for electronics hardware design and ... in Pasadena, Calif., the Design Lab’s mission is to bring together inventors and ... brought to market. , The Design Lab is Supplyframe’s physical representation of one ...
(Date:6/23/2016)... , June 23, 2016  Blueprint Bio, a company ... to the medical community, has closed its Series A ... Nunez . "We have received a commitment ... capital we need to meet our current goals," stated ... us the runway to complete validation on the current ...
(Date:6/23/2016)... ... June 23, 2016 , ... ... regulatory and technical consulting, provides a free webinar on Performing Quality ... 13, 2016 at 12pm CT at no charge. , Incomplete investigations are still ...
Breaking Biology Technology:
(Date:6/2/2016)... YORK , June 2, 2016   The Weather ... is announcing Watson Ads, an industry-first capability in which consumers ... by being able to ask questions via voice or text ... Marketers have long sought ... the consumer, that can be personal, relevant and valuable; and ...
(Date:5/24/2016)... May 24, 2016 Ampronix facilitates superior patient care by providing unparalleled technology ... LCD display is the latest premium product recently added to the range of products ... ... ... 3d Imaging- LCD Medical Display- Ampronix News ...
(Date:5/12/2016)... 12, 2016 , a brand ... overview results from the Q1 wave of its quarterly ... was consumers, receptivity to a program where they would ... health insurance company. "We were surprised to ... Michael LaColla , CEO of Troubadour Research, "primarily ...
Breaking Biology News(10 mins):